RIA
TEVA icon

Realta Investment Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Realta Investment Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,002
Closed -$41K – 1270
2019
Q4 		$41K Buy
4,002
+1,900
+90% +$17K 0.01% 722
2019
Q3 		$14K Sell
2,102
-253
-11% -$1.94K ﹤0.01% 1029
2019
Q2 		$22K Buy
2,355
+53
+2% +$639 0.01% 907
2019
Q1 		$37K Buy
+2,302
New +$40.6K 0.02% 625

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Realta Investment Advisors's TEVA Position: Q1 2020 in Review

Realta Investment Advisors sold out of Teva Pharmaceuticals (TEVA) in Q1 2020, closing a stake of 4,002 shares — an estimated $41K sold.

Realta Investment Advisors first reported a position in TEVA in Q1 2019 and held it in 4 quarters. The position peaked at $41K in Q4 2019. 459 funds tracked by Wall St. Rank hold TEVA as of Q1 2020.

  • Realta Investment Advisors reported no remaining Teva Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Realta Investment Advisors sold 4,002 Teva Pharmaceuticals shares in Q1 2020, an estimated $41K.
  • Realta Investment Advisors first reported a position in Teva Pharmaceuticals in Q1 2019 and held it in 4 quarters.
  • Realta Investment Advisors's Teva Pharmaceuticals position peaked at $41K in Q4 2019.
  • 459 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2020.

Based on Realta Investment Advisors's 13F filing for Q1 2020, filed 23 Apr 2020.